NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
Curasight har afsluttet tegningen af warrants af serien TO2, hvor kun 12,7% blev tegnet, hvilket giver selskabet MDKK 5,4 før emissionsomkostninger. Den lave udnyttelsesgrad skyldes,
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
Curasight har netop udsendt deres Q3 rapport, hvor højdepunkterne er intensiveret diskussioner med Big Pharma, en klar udviklingsstrategi for uTREAT og uTRACE samt fokus på
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: CS Medica, EKOBOT AB, Biotech, Ensurge, Lifecare AS, NORD.investments, Biosergen, Hypefactors, Curasight, Re-Match, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.